Assessing the cost-effectiveness of a once-weekly GLP-1 analogue versus an SGLT-2 inhibitor in the Spanish setting: Once-weekly semaglutide versus empagliflozin

Autor:	Barnaby Hunt, Nino Hallén, Juan José Gorgojo-Martínez, Virginia Martín, Samuel J. P. Malkin
Rok vydání:	2019
Předmět:	medicine.medical_specialty Cost effectiveness Cost-Benefit Analysis Network Meta-Analysis Glucagon-Like Peptides Once weekly Blood Pressure Drug Administration Schedule Diabetes Complications InformationSystems_GENERAL Glucosides Empagliflozin medicine Humans Hypoglycemic Agents GLP-1 Analogue Benzhydryl Compounds Sodium-Glucose Transporter 2 Inhibitors health care economics and organizations Glucagon-like peptide 1 receptor Glycated Hemoglobin Models Statistical business.industry Health Policy Semaglutide Drug Administration Routes Body Weight Type 2 Diabetes Mellitus Diabetes Mellitus Type 2 Spain Emergency medicine Quality-Adjusted Life Years business Healthcare providers Models Econometric
Zdroj:	Journal of medical economics. 23(2)
ISSN:	1941-837X
Popis:	Aims: Controlling costs while maximizing healthcare gains is the predominant challenge for healthcare providers, and therefore cost-effectiveness analysis is playing an ever-increasing role...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bdb83c98c866c7d7552f6000d37a274 https://pubmed.ncbi.nlm.nih.gov/31613199 Zobrazit plný text záznamu